Bayer AG N (BAYN.DE)

Bayer AG N reports an AlphaScore of 43/100 within the Healthcare sector, priced at 43.77 with a market cap of 43 billion. Key metrics feature a gross margin of 58.76% and a negative return on equity of -5.69%. A notable strength is its value sub-score of 72, whereas a clear risk is its low growth sub-score of 6. Evidence is limited to this record's snapshot date of 2026-10-11.

Written 11/10/2026, 00:41:00 UTC · Snapshot 11/10/2026